Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol plasma concentration and BIS during intraoperative awakening in adolescent scoliosis surgery
ChiCTR2500102189Phase 4Not yet recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of propofol in adolescent idiopathic scoliosis (AIS), sponsored by Nanjing Drum-Tower Hospital. Primary endpoints: Plasma concentration of propofol and Bispectral index (BIS). Planned start May 2025; status: not yet recruiting.
02
Drugs
propofol
03
Conditions
adolescent idiopathic scoliosis (AIS)
Beyond the preview
Go deeper on ChiCTR2500102189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102189.